← Leaderboards
Scott Kendall Dessain
Massachusetts General Hospital
$5,388,781
Attributed
$5,388,781
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $487.6K · FY2006–17$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,388,781 · 4
By mechanism
R01$3,857,274 · 1
R21$882,724 · 2
K08$648,783 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Robert H Brown$15,031,077
- James Versalovic$13,934,890
- Jeffrey D Rothstein$32,739,978
- Joseph Vincent Bonventre$46,605,730
- Neal Krishna Devaraj$7,348,652
Others in their field
Top investigators on “Human Monoclonal Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- Peter B. Gilbert · Fred Hutchinson Cancer Center$169,771,074
- Dennis R. Burton · Scripps Research Institute$109,982,030
- Barton F Haynes · Duke University$88,824,253
- Wafaa M. El-Sadr · Columbia University Health Sciences$84,793,830
Research focus
Human Monoclonal AntibodiesCloningAntibodiesTelomeraseIn VivoVaccinesResearch StudyToxinHybridomasTherapeutic AntibodiesMonoclonal AntibodiesUnited StatesResponseBotulinum Toxin Type ANational Institute Of Allergy And Infectious DiseaseBotulinum ToxinsComplexCategoriesBinding (Molecular Function)SerotypingBontoxilysinAffinityCell LineB-Lymphocytes
Grant awards (20)
Immunotoxins based on the IgG response to autologous antigens in cancer patients$225,309
R21 · FY2017 · CA · contact PI
Comprehensive functional assesment of the human antibody response to Enterovirus 71$200,209
R21 · FY2017 · AI · contact PI
Comprehensive functional assesment of the human antibody response to Enterovirus 71$258,209
R21 · FY2016 · AI · contact PI
Immunotoxins based on the IgG response to autologous antigens in cancer patients$198,997
R21 · FY2016 · CA · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$470,828
R01 · FY2014 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$442,579
R01 · FY2013 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$470,828
R01 · FY2012 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$487,554
R01 · FY2011 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$392,964
R01 · FY2010 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$385,891
R01 · FY2009 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$375,096
R01 · FY2008 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$207,684
R01 · FY2007 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$202,479
R01 · FY2007 · AI · contact PI
Human Monoclonal Antibodies that Bind Botulinum Toxins$421,371
R01 · FY2006 · AI · contact PI
PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$129,465
K08 · FY2004 · HL
PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$129,465
K08 · FY2003 · HL
PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$109,984
K08 · FY2002 · HL
PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$19,967
K08 · FY2002 · HL
PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$129,951
K08 · FY2001 · HL
PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$129,951
K08 · FY2000 · HL